Add BrightSurf on Google Email

Improving protein folding may lead to new diabetes treatments

Researchers at Sanford Burnham Prebys Medical Discovery Institute found that enhancing protein-folding processes can help prevent harm to insulin-producing cells. The study revealed the importance of a chaperone protein called binding immunoglobulin protein and its cochaperone protein p58 IPK in maintaining proper proinsulin folding.

SourceSanford Burnham Prebys·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJun 11, 2026

New study finds Americans with severe obesity receive fewer surgeries despite rising need

A new study by Pennington Biomedical and collaborators found that Americans with the highest levels of obesity are undergoing fewer surgical procedures overall. Despite the increasing prevalence of extreme obesity, these individuals appear to be receiving proportionally fewer surgical interventions each year. The research highlights gr...

SourcePennington Biomedical Research Center·JournalObesity·TypeMeta-analysis·DateJun 9, 2026

South and Southeast Asia lead the world on taxing sugary drinks

A new analysis tracks global sugar-sweetened beverage tax adoption across 183 countries, revealing South Asia's significant lead in tax implementation. The study found that countries with higher burdens of type 2 diabetes and obesity are more likely to adopt taxes, but not necessarily those with high rates of sugary drink consumption.

SourceTufts University·JournalThe Lancet Global Health·DateJun 8, 2026

NHS England's "Healthy Living" online program for people with type 2 diabetes may lead to moderate improvements in participants' blood sugar, blood pressure and BMI

The study found that participants in the 'Healthy Living' online program experienced moderate improvements in their blood sugar levels, blood pressure, and body mass index (BMI). The program was designed to support self-management of type 2 diabetes and showed promising results in England.

SourcePLOS·JournalPLOS One·DateJun 3, 2026

Recent advances in the diagnosis and treatment of fat accumulation in liver and pancreas

Researchers highlight latest developments in pathology, diagnosis, and treatment of MASLD and IPFD, revealing correlations with chronic diseases like liver cancer and pancreatic cancer. Innovative treatments, such as AI-driven approaches and organ-targeted therapies, show promise for precision prevention and therapy.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalPortal Hypertension & Cirrhosis·TypeSystematic review·DateJun 1, 2026

Global rules could cut costs and speed access to GLP-1 drugs

A study from UC San Francisco researchers reveals that regulatory differences around the world are slowing the development and adoption of biosimilars. The lack of standardization in biosimilar approval processes is a major obstacle for these cheaper alternatives to expensive biologics, which could lower costs for patients.

SourceUniversity of California - San Francisco·JournalJAMA Health Forum·TypeLiterature review·DateMay 31, 2026

Scientists discover how a father’s obesity affects his children’s metabolism

A new study reveals that metabolic dysfunction in offspring is caused by excess microRNA in sperm from obese fathers. After weight loss, these molecular marks disappear, and offspring develop normally. Research suggests that interventions promoting health and longevity may trigger an increase in this enzyme expression.

Early detection of type 1 diabetes in children is broadly feasible

Researchers have found that screening for early-stage type 1 diabetes in children can be implemented sustainably in general pediatric practice, identifying most children who will later develop stage 3 clinical type 1 diabetes. The study suggests that families without a family history of the disease should also be screened.

Is “yo‑yo dieting” really harmful? New analysis challenges long‑standing assumptions about weight cycling

Weight loss followed by weight regain, known as 'yo-yo dieting,' is not supported by strong scientific evidence. The authors found that benefits of losing weight outweigh the theoretical risks of weight cycling in most cases. Repeated attempts at weight loss can provide meaningful periods of improved metabolic health and quality of life.

SourceDeutsches Zentrum fuer Diabetesforschung DZD·JournalThe Lancet Diabetes & Endocrinology·TypeData/statistical analysis·DateMay 15, 2026

The 28th European Congress of Endocrinology (ECE) hosts the largest gathering of endocrine specialists in Europe

The 28th European Congress of Endocrinology (ECE) 2026 brought together over 4,500 delegates from 111 countries to experience the latest endocrine research and developments. The Congress celebrated the Society's 20th Anniversary and featured groundbreaking studies on hormone disruption, bone development, insulin resistance, and polycys...

Hormone health climbs the policy agenda as endocrine leaders meet for European Society of Endocrinology’s first Summit of the Presidents

The summit brought together endocrine leaders to identify opportunities to work closely together on increasing the visibility of endocrine health in policy decisions. Early findings from a workforce survey revealed challenges including long patient waiting times and retention concerns among early-career clinicians.

Cardiovascular and metabolic diseases are primary drivers of excess US deaths compared to other high-income countries

The US had substantially higher death rates between 1999 and 2022 compared to other wealthy nations, with cardiovascular diseases being the leading cause of excess mortality. An estimated 12.7 million US deaths could have been averted during this period if US mortality rates mirrored those of its peers.

SourceBoston University School of Public Health·JournalJAMA Network Open·TypeObservational study·DateMay 8, 2026

A new mechanism regulating beta cell mass under stress

Researchers at Kyoto University discovered that ATF6α plays a critical role in enabling the survival and proliferation of beta cells under sustained stress, leading to impaired beta cell mass expansion. The study highlights the potential for developing new therapeutic strategies to preserve and restore beta cell mass in diabetes.

SourceKyoto University·JournalDiabetes·TypeExperimental study·DateMay 6, 2026

Central nervous system a key player in diabetes pain

More than 50% of people with diabetes develop diabetic peripheral neuropathy, which causes painful sensations like burning, tingling, or shooting pains. The brain and spinal cord can also contribute to pain, as their pain-blocking systems are less effective in people with diabetes.

SourceMurdoch University·JournalJournal of Diabetes·TypeMeta-analysis·DateMay 3, 2026

Predicting genetic risk for Type 1 diabetes just got more accurate thanks to UC San Diego study

The study demonstrates that the T1GRS tool can identify children and adults at high risk for Type 1 diabetes earlier than current methods, enabling preventive measures before the disease develops. The researchers grouped individuals into four sub-types based on genetic features, each with unique clinical profiles and outcomes.

SourceUniversity of California - San Diego·JournalNature Genetics·TypeComputational simulation/modeling·DateApr 30, 2026

Validation study from Mass General Brigham reveals new tool can predict patients’ genetic risk of eight cardiovascular conditions

Researchers developed a new polygenic risk score (PRS) that estimates a person's inherited risk for eight common cardiovascular conditions. The test combines information from many genetic variants and evaluates a person's risk for coronary artery disease, atrial fibrillation, type 2 diabetes, and more.

SourceMass General Brigham·TypeObservational study·DateApr 29, 2026

Major trial shows continuous glucose monitoring improves blood sugar control in people with type 2 diabetes

A major clinical trial found that real-time continuous glucose monitoring significantly improves blood glucose management in adults with type 2 diabetes treated with basal insulin. Participants using CGM showed greater reductions in HbA1c levels compared to traditional finger prick glucose monitoring.

SourceUniversity of Nottingham·JournalThe Lancet Diabetes & Endocrinology·TypeRandomized controlled/clinical trial·DateApr 23, 2026